Clinical Trials
4 trialsNCT02419495 2025-06-04
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT03009058 2024-11-25
MODULATE
Immodulon Therapeutics Ltd
Phase 1/2 Terminated
NCT01525329 2022-03-15
Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease
The Cleveland Clinic
Phase 3 Terminated
NCT03996252 2020-12-07
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
Tulane University
Phase EARLY_PHASE1 Terminated